arrow
M

Marc A. Bjurlin

University of North Carolina
H指数:40
被引数:6,024

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

APOBEC3 promotes squamous differentiation via IL-1A/AP-1 signaling

APOBEC3通过IL-1A/AP-1信号促进鳞状细胞分化

2025-12-140
OAAI
Spatial Relationships in the Tumor Microenvironment Demonstrate Association with Pathologic Response to Neoadjuvant Chemoimmunotherapy in Muscle-invasive Bladder Cancer
2024-03-018
OA
Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes

UGN-101的给药途径及其对肿瘤学和安全性结果的影响

2023-11-018
PRE
Treatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer With UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS)
2023-10-0110
OA
A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study

Durvalumab联合卡介苗 (BCG) 或体外放射治疗对BCG无反应的非肌肉浸润性膀胱癌患者的1期试验: Hoosier癌症研究网络GU16-243 ADAPT-bt研究

2023-06-0119
OA
Efficacy and Safety of Mitomycin Gel (UGN-101) as an Adjuvant Therapy After Complete Endoscopic Management of Upper Tract Urothelial Carcinoma

丝裂霉素凝胶 (UGN-101) 作为上尿路尿路上皮癌完全内镜治疗后辅助治疗的疗效和安全性

2023-05-0111
PRE